224 related articles for article (PubMed ID: 38072937)
41. Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.
Castle PE; Silva VRS; Consolaro MEL; Kienen N; Bittencourt L; Pelloso SM; Partridge EE; Pierz A; Dartibale CB; Uchimura NS; Scarinci IC
Cancer Prev Res (Phila); 2019 Mar; 12(3):159-170. PubMed ID: 30651294
[TBL] [Abstract][Full Text] [Related]
42. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
[TBL] [Abstract][Full Text] [Related]
43. Comparison of self-collected versus clinician collected cervicovaginal specimens for detection of high risk human papillomavirus among HIV infected women in Ethiopia.
Bogale AL; Teklehaymanot T; Ali JH; Kassie GM; Medhin G; Baye AY; Shiferaw AY
BMC Womens Health; 2022 Sep; 22(1):360. PubMed ID: 36050660
[TBL] [Abstract][Full Text] [Related]
44. Analytical performance of HPV assays on vaginal self-collected vs practitioner-collected cervical samples: the SCoPE study.
Saville M; Hawkes D; Keung M; Ip E; Silvers J; Sultana F; Malloy MJ; Velentzis LS; Canfel L K; Wrede CD; Brotherton J
J Clin Virol; 2020 Jun; 127():104375. PubMed ID: 32361328
[TBL] [Abstract][Full Text] [Related]
45. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
[TBL] [Abstract][Full Text] [Related]
46. Validation of BD Onclarity HPV Assay on Vaginal Self-Samples versus Cervical Samples Using the VALHUDES Protocol.
Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Donders G; Doyen J; Tjalma W; De Sutter P; Peeters E; Vorsters A; Arbyn M
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2177-2184. PubMed ID: 36099441
[TBL] [Abstract][Full Text] [Related]
47. Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA.
Surriabre P; Allende G; Prado M; Cáceres L; Bellot D; Torrico A; Ustariz K; Rojas S; Barriga J; Calle P; Villarroel L; Yañez RM; Baay M; Rodriguez P; Fontaine V
BMC Womens Health; 2017 Dec; 17(1):135. PubMed ID: 29273032
[TBL] [Abstract][Full Text] [Related]
48. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
Lofters A; Devotta K; Prakash V; Vahabi M
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703
[TBL] [Abstract][Full Text] [Related]
49. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Arbyn M; Smith SB; Temin S; Sultana F; Castle P;
BMJ; 2018 Dec; 363():k4823. PubMed ID: 30518635
[TBL] [Abstract][Full Text] [Related]
50. Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions.
Leinonen MK; Schee K; Jonassen CM; Lie AK; Nystrand CF; Rangberg A; Furre IE; Johansson MJ; Tropé A; Sjøborg KD; Castle PE; Nygård M
J Clin Virol; 2018; 99-100():22-30. PubMed ID: 29289814
[TBL] [Abstract][Full Text] [Related]
51. Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India.
Sowjanya AP; Paul P; Vedantham H; Ramakrishna G; Vidyadhari D; Vijayaraghavan K; Laksmi S; Sudula M; Ronnett BM; Das M; Shah KV; Gravitt PE;
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1373-8. PubMed ID: 19423518
[TBL] [Abstract][Full Text] [Related]
52. Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
Rodriguez NM; Brennan LP; Claure L; Balian LN; Champion VL; Forman MR
PLoS One; 2023; 18(3):e0282853. PubMed ID: 36893182
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the self-sampling for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Cáceres L; Bellot D; Ovando N; Torrico A; Calle P; Ascarrunz C; Alexander S; Bossens M; Fontaine V; Rodríguez P
BMC Public Health; 2019 Jan; 19(1):80. PubMed ID: 30654774
[TBL] [Abstract][Full Text] [Related]
54. Performance of a six-methylation-marker assay on self-collected cervical samples - A feasibility study.
Klischke L; von Ehr J; Kohls F; Kampers J; Hülse F; Schmitz M; Hennig A; Dörk T; Hillemanns P; Jentschke M
J Virol Methods; 2021 Sep; 295():114219. PubMed ID: 34175345
[TBL] [Abstract][Full Text] [Related]
55. Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey.
Parker S; Deshmukh AA; Chen B; Lairson DR; Daheri M; Vernon SW; Montealegre JR
Elife; 2023 May; 12():. PubMed ID: 37232493
[TBL] [Abstract][Full Text] [Related]
56. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
57. Community cervical cancer screening: Barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study.
Megersa BS; Bussmann H; Bärnighausen T; Muche AA; Alemu K; Deckert A
PLoS One; 2020; 15(12):e0243036. PubMed ID: 33306681
[TBL] [Abstract][Full Text] [Related]
58. Feasibility of a community-based cervical cancer screening with "test and treat" strategy using self-sample for an HPV test: Experience from rural Cameroon, Africa.
Fokom Domgue J; Futuh B; Ngalla C; Kakute P; Manjuh F; Manga S; Nulah K; Welty E; Schmeler K; Welty T
Int J Cancer; 2020 Jul; 147(1):128-138. PubMed ID: 31633801
[TBL] [Abstract][Full Text] [Related]
59. Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia.
Veerus P; Hallik R; Jänes J; Jõers K; Paapsi K; Laidra K; Innos K
J Med Screen; 2022 Mar; 29(1):53-60. PubMed ID: 34694179
[TBL] [Abstract][Full Text] [Related]
60. Preference for Human Papillomavirus Self-Collection and Papanicolaou: Survey of Underscreened Women in North Carolina.
Kilfoyle KA; Des Marais AC; Ngo MA; Romocki L; Richman AR; Barclay L; Brewer NT; Rahangdale L; Smith JS
J Low Genit Tract Dis; 2018 Oct; 22(4):302-310. PubMed ID: 30179994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
